Mar 16 |
Allakos Inc (ALLK) Reports Increased R&D Expenses and Net Loss in Q4
|
Mar 14 |
Allakos GAAP EPS of -$0.71 misses by $0.20
|
Mar 14 |
Allakos Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
|
Feb 26 |
Allakos Presents Preclinical Data Highlighting Inhibition of MRGPRX2-Mediated Mast Cell Activation with AK006 at AAAAI 2024
|
Jan 18 |
Biotech Stock Roundup: VRTX/CRSP Gene Therapy Label Expansion, ALLK Falls on Update
|
Jan 18 |
Here's Why Allakos Inc. (ALLK) is Poised for a Turnaround After Losing -61.36% in 4 Weeks
|
Jan 17 |
Allakos (ALLK) Plummets 60% on Ending Development of Lead Drug
|
Jan 17 |
Allakos extends losses as analysts downgrade on Phase 2 setback
|
Jan 17 |
ELAB, KIND and RLX among pre-market losers
|
Jan 17 |
Netflix To Rally Over 13%? Here Are 10 Top Analyst Forecasts For Wednesday
|